The role of experts and their testimony in highly technical matters is indispensable. An expert is generally relied upon to prove or disprove […]

Biosimilars are highly similar to the reference product notwithstanding minor differences in clinically inactive components. There are no clinically meaningful differences between the […]

From being the youngest self-made billionaire to being the CEO of a company hanging on by threads, Elizabeth Holmes had witnessed her rise […]

What is IL&FS? The Infrastructure Leasing & Finance Services (IL&FS) Ltd. is a core investment company with most business operations domiciled in separate […]

Recent efforts by the government, investors and innovators have helped facilitate the growth of budding businesses in India. While the initial plans for […]

Giving tough competition to the climate, the Cricket World Cup Fever is soaring high on the temperature scale. Every brilliant shot is already […]

The Reserve Bank of India (“RBI“) released the “Draft Enabling Framework for Regulatory Sandbox” on 18th April 2019 (“Draft Framework“). The Regulatory Sandbox […]

Substances used for in vitro diagnosis, medical device, mechanical contraceptives, disinfectants and insecticides and other notified devices in India are now regulated by […]

India released the draft regulatory guidelines for ‘Similar Biologics’ at the BIO industry conference in Boston, USA, on 19 June 2012. These guidelines […]

The principles involved in awarding of damages in IP litigation in India have seen a great evolution in the recent past. The landscape […]